Patent details

EP2116541 Title: Proline derivatives and their use as dipeptidyl peptidase IV inhibitors

Basic Information

Publication number:
EP2116541
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP091666453
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
French Title of Invention:
Dérivés de proline et leur utilisation en tant qu'inhibiteurs de la dipeptidyl-peptidase IV
German Title of Invention:
Prolinderivate und deren Verwendung als Dipeptidylpeptidase-IV-Inhibitoren
SPC Number:

Dates

Filing date:
29/04/2005
Grant date:
25/02/2015
EP Publication Date:
25/02/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/11/2009
EP B1 Publication Date:
25/02/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/04/2015
Expiration date:
29/04/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/04/2005
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, CT 06340, United States (US)

Inventor

1

Name:
Hulin Bernard
Address:
United States (US)

2

Name:
Piotrowski David, Walter
Address:
United States (US)

Priority

1

Priority Number:
570300 P
Priority Date:
12/05/2004
Priority Country:
United States (US)

2

Priority Number:
664305 P
Priority Date:
21/03/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 401/14;
Filing date Document type Number of pages